CCR5 and colorectal carcinoma: In mouse models of various cancer types, including colorectal cancer (CRC), gastric cancer, and breast cancer, CCR5 inhibitors, including maraviroc, vicriviroc, and TAK‐779, have demonstrated antitumor effects.317